跳至主要内容
临床试验/NCT02572765
NCT02572765Unknown不适用

Evaluation of Splenic Metabolic Activity With 18FDG-PET in Hypertension

Neuromed IRCCS1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年1月2日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Splenic metabolic activity

研究概览

简要总结

The purpose of this study is to evaluate the splenic activation in hypertensive patients, as compared to normotensives, using FDG-PET/CT imaging. Moreover, the investigators will investigate whether the splenic metabolic activity relates to the expression of circulating inflammatory proteins (high-sensitivity C-reactive protein [hsCRP]), interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a) or to immune profiles of activated T cells.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • absence of prior cancer diagnosis or remission from cancer at the time of FDG-PET/CT imaging (from at least 6 months)
  • age ≥ 30 and ≤ 85 years
  • absence of acute cardio/cerebrovascular disease (myocardial infarction, stroke, transient ischemic attack, revascularization)
  • absence of acute or chronic inflammatory or autoimmune disease
  • diagnosis of presence/absence of hypertension, on the basis of documented medical history

排除标准

  • atrial fibrillation
  • use of anti-inflammatory drugs in the week preceding the FDG-PET/CT imaging
  • chronic use of anti-inflammatory drugs

结局指标

主要结局

Splenic metabolic activity

时间窗: At enrollment

18FDG uptake in splenic tissue

次要结局

  • Circulating pro-inflammatory markers(At enrollment)

研究者

发起方
Neuromed IRCCS
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuseppe Lembo

prof. Giuseppe Lembo

Neuromed IRCCS

研究点 (1)

Loading locations...

相似试验